LU93142I2 - Agent oleogelifiant contenant du triterpene, oleogel contenant du triterpene et procede de fabrication d'un agent oleogelifiant contenant du triterpene - Google Patents

Agent oleogelifiant contenant du triterpene, oleogel contenant du triterpene et procede de fabrication d'un agent oleogelifiant contenant du triterpene Download PDF

Info

Publication number
LU93142I2
LU93142I2 LU93142C LU93142C LU93142I2 LU 93142 I2 LU93142 I2 LU 93142I2 LU 93142 C LU93142 C LU 93142C LU 93142 C LU93142 C LU 93142C LU 93142 I2 LU93142 I2 LU 93142I2
Authority
LU
Luxembourg
Prior art keywords
containing triterpene
oleogel
agent containing
triterpene
producing
Prior art date
Application number
LU93142C
Other languages
English (en)
Original Assignee
Birken Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34971468&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU93142(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Birken Gmbh filed Critical Birken Gmbh
Publication of LU93142I2 publication Critical patent/LU93142I2/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
    • C07C35/37—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with a hydroxy group on a condensed system having three rings
    • C07C35/42—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with a hydroxy group on a condensed system having three rings derived from the phenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Colloid Chemistry (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Measuring Volume Flow (AREA)
LU93142C 2004-06-22 2016-07-06 Agent oleogelifiant contenant du triterpene, oleogel contenant du triterpene et procede de fabrication d'un agent oleogelifiant contenant du triterpene LU93142I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004030044A DE102004030044A1 (de) 2004-06-22 2004-06-22 Triterpenhaltiger Oleogelbildner, triterpenhaltiges Oleogel und Verfahren zur Herstellung eines triterpenhaltigen Oleogels
PCT/EP2005/006710 WO2005123037A1 (fr) 2004-06-22 2005-06-21 Agent oleogelifiant contenant du triterpene, oleogel contenant du triterpene et procede de fabrication d'un agent oleogelifiant contenant du triterpene

Publications (1)

Publication Number Publication Date
LU93142I2 true LU93142I2 (fr) 2016-09-06

Family

ID=34971468

Family Applications (1)

Application Number Title Priority Date Filing Date
LU93142C LU93142I2 (fr) 2004-06-22 2016-07-06 Agent oleogelifiant contenant du triterpene, oleogel contenant du triterpene et procede de fabrication d'un agent oleogelifiant contenant du triterpene

Country Status (31)

Country Link
US (2) US8536380B2 (fr)
EP (1) EP1758555B2 (fr)
JP (1) JP4468987B2 (fr)
KR (1) KR101162991B1 (fr)
CN (1) CN1972668B (fr)
AT (1) ATE423546T1 (fr)
AU (1) AU2005253732C1 (fr)
BE (1) BE2016C035I2 (fr)
BR (1) BRPI0512288B8 (fr)
CA (1) CA2571606C (fr)
CY (2) CY1109066T1 (fr)
DE (2) DE102004030044A1 (fr)
DK (1) DK1758555T4 (fr)
ES (1) ES2323082T5 (fr)
FR (1) FR16C1003I2 (fr)
HU (1) HUS1600032I1 (fr)
IL (1) IL180057A (fr)
LT (1) LTC1758555I2 (fr)
LU (1) LU93142I2 (fr)
MX (1) MXPA06015233A (fr)
NL (1) NL300823I2 (fr)
NO (2) NO336747B1 (fr)
NZ (1) NZ552280A (fr)
PL (1) PL1758555T5 (fr)
PT (1) PT1758555E (fr)
RS (1) RS50832B2 (fr)
RU (1) RU2430717C2 (fr)
SI (1) SI1758555T2 (fr)
UA (1) UA88308C2 (fr)
WO (1) WO2005123037A1 (fr)
ZA (1) ZA200610304B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2332525A1 (fr) 2009-11-23 2011-06-15 Novaliq GmbH Composition pharmaceutique comprenant du propofol
DE102009047092A1 (de) * 2009-11-24 2011-05-26 Birken Gmbh Verwendung eines triterpenhaltigen Oleogels zur Wundheilung
EP2335675B1 (fr) 2009-12-10 2015-02-18 Neubourg Skin Care GmbH & Co. KG Formules de mousse sans émulsifiant et stabilisées par polymères
PL2363108T3 (pl) 2010-03-02 2018-04-30 Neubourg Skin Care Gmbh & Co. Kg Formulacje piankowe zawierające co najmniej jeden triterpenoid
CN103889434B (zh) 2011-06-21 2017-02-15 Bvw控股公司 含有乳香酸的医疗装置
US20190281853A1 (en) * 2016-05-12 2019-09-19 Rudjer Boskovic Institute Low molecular weight organic gelators of vegetable oil
JP2019524755A (ja) * 2016-07-18 2019-09-05 アムリット・リサーチ・リミテッド ベツリン含有油中水型泡沫及びその組成物
US20180258277A1 (en) * 2017-03-10 2018-09-13 Kraton Polymers U.S. Llc Fusible oil gel compositions and methods of making and using same
KR102692754B1 (ko) 2017-08-31 2024-08-08 (주)아모레퍼시픽 병풀 추출물 또는 이로부터 유래한 트리테르펜을 고함량으로 포함하는 화장료 조성물 및 이의 제조 방법
CA3081436A1 (fr) 2017-10-31 2019-05-09 Western Oncolytics Ltd. Vecteur de plateforme oncolytique pour administration systemique
EP3735274A1 (fr) 2018-01-04 2020-11-11 Amryt Research Limited Extraits d'écorce de bouleau contenant de la bétuline et leur formulation
CA3117842A1 (fr) 2018-10-26 2020-04-30 Viramal Limited Composition de gel mucoadhesif
EP3659583B1 (fr) 2018-11-30 2023-06-07 Viramal Limited Procédé de préparation d'un agent coagulant, agent coagulant ainsi obtenu et utilisation de cet agent coagulant
CN109512780A (zh) * 2019-01-09 2019-03-26 河南省医药科学研究院 一种凝胶药膏及其制备方法和应用
GR1010072B (el) * 2019-05-15 2021-09-15 Αριστοτελειο Πανεπιστημιο Θεσσαλονικης - Ειδικος Λογαριασμος Κονδυλιων Ερευνας Βρωσιμα κτηνιατρικα σκευασματα ενδομαστικης προστασιας θηλαστικων και μεθοδος για την παρασκευη τους
JP2024516400A (ja) 2021-04-30 2024-04-15 カリヴィル イムノセラピューティクス， インコーポレイテッド 修飾されたｍｈｃ発現のための腫瘍溶解性ウイルス

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU83173A1 (fr) * 1981-02-27 1981-06-05 Oreal Nouvelles compositions cosmetiques pour le traitement des cheveux et de la peau contenant une poudre resultant de la pulverisation d'au moins une plante et un agent de cohesion
JP3363161B2 (ja) 1991-06-27 2003-01-08 ポーラ化成工業株式会社 非水ゲル化粧料
US5750578A (en) * 1997-02-11 1998-05-12 Regents Of The University Of Minnesota Use of betulin and analogs thereof to treat herpesvirus infection
US6403816B1 (en) * 1997-09-30 2002-06-11 Dabur Research Foundation Betulinic acid derivatives having antiangiogenic activity, processes for producing such derivatives and their use for treating tumor associated angiogenesis
FR2779438B1 (fr) * 1998-06-03 2004-12-24 Jean Marc Aiache Gel stable, son procede de preparation, et compositions pharmaceutiques le comprenant
GB9908593D0 (en) 1999-04-16 1999-06-09 Quest Int Dental compositions containing boswellia extracts
AU784718B2 (en) 1999-07-09 2006-06-01 Bsp Pharma A/S Composition containing extracts of Butyrospermum parkii and the use as medicament or dietary supplement
ATE262283T1 (de) * 2000-02-10 2004-04-15 Loders Croklaan Bv Fettmischungen mit kristallmodifikatoren
DE10056902A1 (de) * 2000-11-16 2002-05-23 Birken Gmbh Verfahren zur Gewinnung von Triterpenen aus Pflanzen sowie deren Verwendung
JP4593864B2 (ja) 2000-03-28 2010-12-08 ビルケン ゲーエムベーハー 植物抽出物を含有するエマルション、前記エマルションの製造方法並びに植物抽出物の獲得方法
US6689767B2 (en) * 2000-09-29 2004-02-10 Regents Of The University Of Minnesota Triterpenes having antibacterial activity
US6642217B2 (en) * 2000-09-29 2003-11-04 Naturtek, Llc Triterpenes having human antifungal and antiyeast activity
JP2002138014A (ja) 2000-10-31 2002-05-14 Noevir Co Ltd 微細エマルション組成物
DE10143964A1 (de) 2001-09-07 2003-03-27 Basf Ag Emulgatorarme oder emulgatorfreie Systeme vom Typ Öl-in-Wasser mit einem Gehalt an Stabilisatoren und einem aminosubstituierten Hydroxybenzophenon
DE10156297A1 (de) * 2001-11-19 2003-05-28 Henkel Kgaa Mittel zum Schutz der Haut
JP2003335627A (ja) 2002-03-14 2003-11-25 Lion Corp 化粧料含浸シート
DE10237281A1 (de) 2002-08-14 2004-03-04 Birken Gmbh Vorrichtung zur kontinuierlichen Extraktion von Extraktstoffen aus Pflanzen
JP3779661B2 (ja) 2002-09-13 2006-05-31 花王株式会社 皮膚化粧料
KR100489701B1 (ko) * 2002-10-09 2005-05-16 주식회사 태평양 고농도의 트리터페노이드를 함유하는 미소화 리포좀 및 그제조방법
JP2005004911A (ja) 2003-06-13 2005-01-06 Ikuta Insatsu Kk 磁気カード
DE10329955A1 (de) * 2003-07-03 2005-02-03 Merck Patent Gmbh Verwendung eines hydroalkoholischen Extrakts aus Bauhinia zur Herstellung einer Zubereitung

Also Published As

Publication number Publication date
HUS1600032I1 (hu) 2016-08-29
IL180057A0 (en) 2007-05-15
CY2016025I2 (el) 2016-10-05
RU2007102084A (ru) 2008-07-27
NL300823I2 (nl) 2017-06-22
PL1758555T3 (pl) 2009-07-31
NO2016012I1 (no) 2016-07-07
PL1758555T5 (pl) 2011-12-30
CY2016025I1 (el) 2016-10-05
ZA200610304B (en) 2007-11-28
DK1758555T4 (da) 2011-12-19
CN1972668B (zh) 2013-01-09
FR16C1003I1 (fr) 2016-08-26
ES2323082T3 (es) 2009-07-06
ES2323082T5 (es) 2012-01-05
CN1972668A (zh) 2007-05-30
NO20070390L (no) 2007-03-16
MXPA06015233A (es) 2007-12-12
CA2571606A1 (fr) 2005-12-29
AU2005253732A1 (en) 2005-12-29
BRPI0512288A (pt) 2008-03-25
CA2571606C (fr) 2011-07-19
WO2005123037A1 (fr) 2005-12-29
EP1758555B1 (fr) 2009-02-25
RS50832B2 (sr) 2018-09-28
KR20070046821A (ko) 2007-05-03
NZ552280A (en) 2010-10-29
ATE423546T1 (de) 2009-03-15
JP4468987B2 (ja) 2010-05-26
RU2430717C2 (ru) 2011-10-10
DE502005006701D1 (de) 2009-04-09
KR101162991B1 (ko) 2012-07-10
EP1758555A1 (fr) 2007-03-07
AU2005253732C1 (en) 2010-01-21
AU2005253732B2 (en) 2009-07-16
SI1758555T1 (sl) 2009-08-31
CY1109066T1 (el) 2014-07-02
DE102004030044A1 (de) 2006-01-12
EP1758555B2 (fr) 2011-09-07
RS50832B (sr) 2010-08-31
US8536380B2 (en) 2013-09-17
BE2016C035I2 (fr) 2024-10-08
BRPI0512288B8 (pt) 2021-05-25
IL180057A (en) 2013-11-28
BRPI0512288B1 (pt) 2019-05-21
PT1758555E (pt) 2009-04-24
JP2008503530A (ja) 2008-02-07
UA88308C2 (ru) 2009-10-12
DK1758555T3 (da) 2009-06-22
FR16C1003I2 (fr) 2018-01-19
US20140050790A1 (en) 2014-02-20
NO336747B1 (no) 2015-10-26
US8828444B2 (en) 2014-09-09
US20070299285A1 (en) 2007-12-27
NO2016012I2 (no) 2016-07-07
SI1758555T2 (sl) 2009-08-31
LTC1758555I2 (lt) 2017-11-10

Similar Documents

Publication Publication Date Title
LU93142I2 (fr) Agent oleogelifiant contenant du triterpene, oleogel contenant du triterpene et procede de fabrication d'un agent oleogelifiant contenant du triterpene
TW200606581A (en) A chemically amplified positive resist composition, a haloester derivative and a process for producing the same
WO2007124092A3 (fr) Composés et compositions générateurs de photoacides
TW200707090A (en) Lithographic apparatus and device manufacturing method
DE602006009229D1 (de) Aerosolabscheider
AR047526A1 (es) Halogenoalquilcarboxamidas
CR7901A (es) Pirazolilcarboxanilidas para la lucha contra los microorganismos indeseados
ATE534650T1 (de) Neue cyanothiazolide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
SG10201406358SA (en) Antibody purification
MY150736A (en) Mousse
UA91910C2 (ru) Композиция для борьбы с заболеваниями, вызванными фитопатогенными микроорганизмами, и способ борьбы с заболеваниями, вызванными фитопатогенными микроорганизмами, на полезных растениях или на материале для их размножения
TW200508300A (en) Composition and method for removing copper-compatible resist
WO2008062276A8 (fr) Dérivés d'acétylène comme inhibiteurs de la stéaroyl coa désaturase
CR8879A (es) Bifeniltiazolcarboxamidas
CR8360A (es) 1,3 dimetilbutilcarboxanilidas
DE602006009144D1 (de) Zusammensetzungen für die verbesserung der darmgesundheit und der tierischen leistung enthaltend beta-glucans and alfa-fucans
SE0303476D0 (sv) Device, method and use for the formation of small particles
ITMI20040498A1 (it) Composizioni granulari
ATE418873T1 (de) Zusammensetzung die sich als sahneersatz eignet sowie verfahren zu deren herstelung
CR8073A (es) Iodopyrazolyl carboxanilidas
MY141850A (en) Pharmaceutically active diazepanes
FR2932906B1 (fr) Procede de simulation de la ventilation d'un reservoir liquide.
WO2004074928A3 (fr) Composition de photoresine pour lithographie a ultraviolet profond
CR7405A (es) Difluormetiltiazolilcarboxanilidas
UA36285U (ru) Способ определения состояния активности кислой фосфатазы лимфоцитов